Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Diamyd® in Patients With LADA (Latent Autoimmune Diabetes in Adult)
This study is ongoing, but not recruiting participants.
Study NCT00456027   Information provided by Diamyd Therapeutics AB
First Received: April 3, 2007   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 1
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Additional drug interventions recognized in this trial
Aluminum Hydroxide
More general drug interventions related to this trial
Adjuvants, Immunologic
Antacids
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Diamyd Therapeutics AB


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services